Company overview

Rapid Micro Biosystems is a life sciences technology company providing automation solutions that improve the manufacturing process and enable the fast, safe release of critical healthcare products like biologics, vaccines, cell and gene therapies, and sterile injectables. We are a trusted partner in quality control microbiology automation, helping customers enhance lives and improve patient outcomes.Our vision is realized through the Growth Direct® System.The Growth Direct® platform replaces outdated, manual microbiology testing in large pharmaceutical manufacturing operations worldwide. By bringing quality control directly to the manufacturing floor, Growth Direct® enables faster, more accurate results, greater efficiency, and improved compliance with data integrity standards. These benefits help our customers make quicker, more informed decisions and ensure a reliable supply of vital healthcare products.Our company values guide us in achieving our vision:•Customer-Driven: We are committed to delivering high-quality products and services.•Respect: We embrace diversity and foster trust within our teams.•Grit: We face challenges with determination and find solutions.•One RMB: We work together as one unified team, driven by a shared purpose.The company is headquartered in Lexington, Massachusetts, and has U.S. manufacturing in Lowell, Massachusetts, and global locations in Switzerland, Germany, and the Netherlands.
Founded in 2006
Lexington, Massachusetts, USA
207 employees (4 in marketing)
76% recommend to a friend
77% positive business outlook

Salaries

Typical salary range

$155,000 – $170,000

/ yr

Help build salary transparency at Rapid Micro Biosystems

Share your compensation anonymously to see full data.

Contribute

People

Headcount trend

Company growth over the last 12 months

Headcount +3.5% year over year

Funding

Total funding

$422.4M

Last raise

$45M

Post IPO Debt, 7 months ago

Funding history

Aug 2025

Post IPO Debt Rapid Micro Biosystems · $45M

Mar 2021

Private Equity Round Rapid Micro Biosystems · $81M

May 2020

Private Equity Round Rapid Micro Biosystems · $120M

May 2018

Private Equity Round Rapid Micro Biosystems · $60M

Apr 2015

Series C Rapid Micro Biosystems · $25M

Mar 2015

Debt Financing Rapid Micro Biosystems · $6M

Audience

Monthly website visitors
5.6K
Month over month+13.4%
Quarter over quarter-4.5%
Top sourceDirect (46.6%)
Ad budget per month$2.5K
Average search rank42.6
Traffic source mix
Direct
46.6%
Search
29.7%
Social
12.9%
Referral
7.3%
Paid referral
1.4%

LinkedIn followers

Follower count and growth

Total followers

15.9K

12-mo growth

+12%

Monthly growth

+5.1%

News

Links